These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 9647570)
1. Expression of cadherins and CD44 isoforms in ovarian endometrial cysts. Daraï E; Leblanc M; Walker-Combrouze F; Bringuier AF; Madelenat P; Scoazec JY Hum Reprod; 1998 May; 13(5):1346-52. PubMed ID: 9647570 [TBL] [Abstract][Full Text] [Related]
2. Soluble adhesion molecules in serum and cyst fluid from patients with cystic tumours of the ovary. Daraï E; Bringuier AF; Walker-Combrouze F; Feldmann G; Madelenat P; Scoazec JY Hum Reprod; 1998 Oct; 13(1O):2831-5. PubMed ID: 9804241 [TBL] [Abstract][Full Text] [Related]
3. Analysis of CD44 expression in serous and mucinous borderline tumours of the ovary: comparison with cystadenomas and overt carcinomas. Darai E; Walker-Combrouze F; Fauconnier A; Madelenat P; Potet F; Scoazec JY Histopathology; 1998 Feb; 32(2):151-9. PubMed ID: 9543672 [TBL] [Abstract][Full Text] [Related]
4. Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts. Sundfeldt K; Ivarsson K; Rask K; Haeger M; Hedin L; Brännström M Anticancer Res; 2001; 21(1A):65-70. PubMed ID: 11299791 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of Oct-4, CD44, and E-cadherin in eutopic and ectopic endometrium in ovarian endometriomas and their correlations with clinicopathological variables. Sancakli Usta C; Turan G; Bulbul CB; Usta A; Adali E Reprod Biol Endocrinol; 2020 Nov; 18(1):116. PubMed ID: 33218351 [TBL] [Abstract][Full Text] [Related]
6. Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours. Daraï E; Detchev R; Hugol D; Quang NT Hum Reprod; 2003 Aug; 18(8):1681-5. PubMed ID: 12871882 [TBL] [Abstract][Full Text] [Related]
7. Expression of cadherins and CD44 isoforms in human endometrium and peritoneal endometriosis. Poncelet C; Leblanc M; Walker-Combrouze F; Soriano D; Feldmann G; Madelenat P; Scoazec JY; Daraï E Acta Obstet Gynecol Scand; 2002 Mar; 81(3):195-203. PubMed ID: 11966474 [TBL] [Abstract][Full Text] [Related]
8. Comparison of RCAS1 and metallothionein expression and the presence and activity of immune cells in human ovarian and abdominal wall endometriomas. Wicherek L; Dutsch-Wicherek M; Galazka K; Banas T; Popiela T; Lazar A; Kleinrok-Podsiadlo B Reprod Biol Endocrinol; 2006 Aug; 4():41. PubMed ID: 16907986 [TBL] [Abstract][Full Text] [Related]
9. Phospholipase A2 group IIA is elevated in endometriomas but not in peritoneal fluid and serum of ovarian endometriosis patients. Kocbek V; Bersinger NA; Brglez V; Mueller MD; Petan T; Rižner TL Gynecol Endocrinol; 2015 Mar; 31(3):214-8. PubMed ID: 25366587 [TBL] [Abstract][Full Text] [Related]
10. Aberrant Methylation of the E-Cadherin Gene Promoter Region in Endometrium and Ovarian Endometriotic Cysts of Patients with Ovarian Endometriosis. Li Y; An D; Guan YX; Kang S Gynecol Obstet Invest; 2017; 82(1):78-85. PubMed ID: 27023436 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors. Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256 [TBL] [Abstract][Full Text] [Related]
12. Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases. Daraï E; Scoazec JY; Walker-Combrouze F; Mlika-Cabanne N; Feldmann G; Madelenat P; Potet F Hum Pathol; 1997 Aug; 28(8):922-8. PubMed ID: 9269828 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer. Sliutz G; Tempfer C; Winkler S; Kohlberger P; Reinthaller A; Kainz C Br J Cancer; 1995 Dec; 72(6):1494-7. PubMed ID: 8519665 [TBL] [Abstract][Full Text] [Related]
14. CA 125 concentrations in ovarian 'chocolate' cyst fluid can differentiate an endometriotic cyst from a cystic corpus luteum. Koninckx PR; Muyldermans M; Moerman P; Meuleman C; Deprest J; Cornillie F Hum Reprod; 1992 Oct; 7(9):1314-7. PubMed ID: 1479017 [TBL] [Abstract][Full Text] [Related]
15. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas. Zheng J; Benedict WF; Xu HJ; Hu SX; Kim TM; Velicescu M; Wan M; Cofer KF; Dubeau L J Natl Cancer Inst; 1995 Aug; 87(15):1146-53. PubMed ID: 7674319 [TBL] [Abstract][Full Text] [Related]
16. Expression of apoptosis-related proteins in endometriomas and benign and malignant ovarian tumours. Fauvet R; Poncelet C; Hugol D; Lavaur A; Feldmann G; Daraï E Virchows Arch; 2003 Jul; 443(1):38-43. PubMed ID: 12756564 [TBL] [Abstract][Full Text] [Related]
17. Secretory leukocyte protease inhibitor in ovarian endometriomas following GnRH agonist therapy. Suzumori N; Sato M; Ikuta K; Suzumori K Obstet Gynecol; 2001 Apr; 97(4):561-6. PubMed ID: 11275028 [TBL] [Abstract][Full Text] [Related]
18. Alteration of CD44 and cadherins expression: possible association with augmented aggressiveness and invasiveness of endometrial carcinoma. Leblanc M; Poncelet C; Soriano D; Walker-Combrouze F; Madelenat P; Scoazec JY; Darai E Virchows Arch; 2001 Jan; 438(1):78-85. PubMed ID: 11213839 [TBL] [Abstract][Full Text] [Related]